Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.

Elsayed M, Moawad MHED, Elkholy M, Ahmed Y, Nabgouri Y, Bahtiyarova G, Alkhawaldeh IM, Abouzid M, Wagih RM

Open source

DOI
10.1007/s00228-025-03860-4
Published
2025 Sep
Container
European journal of clinical pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-025-03860-4,
  title = {Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.},
  author = {Elsayed M and Moawad MHED and Elkholy M and Ahmed Y and Nabgouri Y and Bahtiyarova G and Alkhawaldeh IM and Abouzid M and Wagih RM},
  year = {2025},
  journal = {European journal of clinical pharmacology},
  doi = {10.1007/s00228-025-03860-4},
  url = {https://doi.org/10.1007/s00228-025-03860-4}
}

RIS

TY  - JOUR
TI  - Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.
AU  - Elsayed M
AU  - Moawad MHED
AU  - Elkholy M
AU  - Ahmed Y
AU  - Nabgouri Y
AU  - Bahtiyarova G
AU  - Alkhawaldeh IM
AU  - Abouzid M
AU  - Wagih RM
PY  - 2025
JO  - European journal of clinical pharmacology
DO  - 10.1007/s00228-025-03860-4
UR  - https://doi.org/10.1007/s00228-025-03860-4
ER  - 

APA

M, E., MHED, M., M, E., Y, A., Y, N., G, B., IM, A., M, A., & RM, W. (2025). Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.. European journal of clinical pharmacology. https://doi.org/10.1007/s00228-025-03860-4

Source records